NervGen Pharma Corporation (QB) (NGENF)
USOTC
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current NGENF market cap is 132.64M. The company's latest EPS is CAD -0.3189 and P/E is -8.22.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.4M | -9.93M | -11.14M | -21.98M | -16.94M |
| Net Income | -9.77M | -11.19M | -12.73M | -20.72M | -22.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 6.77M | 6.68M | 17.9M | 23.88M | 13.24M |
| Total Liabilities | 924k | 755k | 1.08M | 10.41M | 15.25M |
| Total Equity | 5.84M | 5.92M | 16.82M | 13.46M | -2.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -8.09M | -6.31M | -8.27M | -17.78M | -11.3M |
| Investing | N/A | -3k | -44k | -21k | -139k |
| Financing | 9.84M | 7.85M | 19.61M | 22.64M | 766k |
| Market Cap | 132.64M |
| Price to Earnings Ratio | -8.22 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 15.77 |
| Price to Book Ratio | -91.52 |
| Dividend Yield | - |
| Shares Outstanding | 70.18M |
| Average Volume (1 week) | 42.71k |
| Average Volume (1 Month) | 46.99k |
| 52 Week Change | 44.27% |
| 52 Week High | 2.99 |
| 52 Week Low | 1.16 |
| Spread (Intraday) | 0.17 (8.5%) |
| Company Name | NervGen Pharma Corporation (QB) |
| Address |
1133 melville street, suite 3500, the stack vancouver, british columbia V6E 4E5 |
| Website | https://nervgen.com/ |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
